title: Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy.
authors.affiliation: Huntsman Cancer Institute, Deininger/O'Hare Research Laboratory, University of Utah, Salt Lake City, UT, USA.|Centre for Haematology, Hammersmith Hospital, Department of Cellular Pathology, Imperial College London, London, UK.
authors.forename: J S
authors.initials: JS
authors.lastname: Khorashad
authors.affiliation: Huntsman Cancer Institute, Deininger/O'Hare Research Laboratory, University of Utah, Salt Lake City, UT, USA.
authors.forename: S K
authors.initials: SK
authors.lastname: Tantravahi
authors.affiliation: Huntsman Cancer Institute, Deininger/O'Hare Research Laboratory, University of Utah, Salt Lake City, UT, USA.
authors.forename: D
authors.initials: D
authors.lastname: Yan
authors.affiliation: Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
authors.forename: C C
authors.initials: CC
authors.lastname: Mason
authors.affiliation: Department of Human Genetics, University of Utah, Salt Lake City, UT, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Qiao
authors.affiliation: Huntsman Cancer Institute, Deininger/O'Hare Research Laboratory, University of Utah, Salt Lake City, UT, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Eiring
authors.affiliation: Molecular Diagnostics Laboratory, Biorepository and Molecular Pathology Core at Huntsman Cancer Institute, Department of Pathology, University of Utah, Salt Lake City, UT, USA.
authors.forename: K
authors.initials: K
authors.lastname: Gligorich
authors.affiliation: Huntsman Cancer Institute, Deininger/O'Hare Research Laboratory, University of Utah, Salt Lake City, UT, USA.
authors.forename: T
authors.initials: T
authors.lastname: Hein
authors.affiliation: Huntsman Cancer Institute, Deininger/O'Hare Research Laboratory, University of Utah, Salt Lake City, UT, USA.
authors.forename: A D
authors.initials: AD
authors.lastname: Pomicter
authors.affiliation: Centre for Haematology, Hammersmith Hospital, Department of Cellular Pathology, Imperial College London, London, UK.
authors.forename: A G
authors.initials: AG
authors.lastname: Reid
authors.affiliation: Department of Pathology, University of Utah, Salt Lake City, UT, USA.
authors.forename: T W
authors.initials: TW
authors.lastname: Kelley
authors.affiliation: Department of Human Genetics, University of Utah, Salt Lake City, UT, USA.
authors.forename: G T
authors.initials: GT
authors.lastname: Marth
authors.affiliation: Huntsman Cancer Institute, Deininger/O'Hare Research Laboratory, University of Utah, Salt Lake City, UT, USA.|Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
authors.forename: T
authors.initials: T
authors.lastname: O'Hare
authors.affiliation: Huntsman Cancer Institute, Deininger/O'Hare Research Laboratory, University of Utah, Salt Lake City, UT, USA.|Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Deininger
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D015477:Leukemia, Myelomonocytic, Chronic / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D009154:Mutation
chemical_list: D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate